Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence.

Spahn, Martin

Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence. [electronic resource] - International journal of cancer Jul 2010 - 394-403 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1097-0215

10.1002/ijc.24715 doi


Aged
Biomarkers, Tumor--genetics
Cohort Studies
Computational Biology
Disease Progression
Humans
Lymphatic Metastasis
Male
MicroRNAs--physiology
Middle Aged
Neoplasm Recurrence, Local--diagnosis
Oligonucleotide Array Sequence Analysis
Prostatic Hyperplasia--genetics
Prostatic Neoplasms--genetics
RNA, Messenger--genetics
Reverse Transcriptase Polymerase Chain Reaction